{
  "dataset_name": "Medicare GLP-1 Spending by Prescriber State",
  "dataset_version": "1.0.0",
  "verified_date": "2026-08-01",
  "national_2024": {
    "gross_drug_cost_usd": "27503414515.35",
    "claims": "21825833",
    "standardized_30_day_fills": "29286812.4",
    "gross_cost_per_claim_usd": "1260.13",
    "gross_cost_per_standardized_30_day_fill_usd": "939.11",
    "age_65_plus_gross_drug_cost_usd": "21521351273.45",
    "age_65_plus_share_pct": "78.2497"
  },
  "national_2023": {
    "gross_drug_cost_usd": "22204068493.62",
    "claims": "16229271",
    "standardized_30_day_fills": "22753714.3"
  },
  "change_2023_to_2024": {
    "gross_drug_cost_pct": "23.8666",
    "claims_pct": "34.4844",
    "standardized_30_day_fills_pct": "28.7122"
  },
  "state_and_dc_2024": {
    "gross_drug_cost_usd": "27365405390.12",
    "share_of_national_pct": "99.4982",
    "national_less_states_dc_usd": "138009125.23"
  },
  "scope_sensitivity": {
    "excluded_fixed_ratio_combo_gross_cost_2024_usd": "391312777.27",
    "headline_plus_fixed_ratio_combo_gross_cost_2024_usd": "27894727292.62",
    "fixed_ratio_combo_increment_over_headline_pct": "1.4228"
  },
  "state_product_reporting_2024": {
    "possible_state_product_cells": 561,
    "reported_state_product_cells": 518,
    "cells_without_a_reportable_cms_row": 43,
    "missing_row_semantics": "No reportable CMS state-product row; do not interpret as a confirmed zero."
  },
  "state_age_65_plus_suppression_2024": {
    "suppressed_age_65_plus_utilization_product_cells": 23,
    "suppressed_age_65_plus_beneficiary_product_cells": 56,
    "affected_jurisdiction_count": 21,
    "affected_jurisdictions": [
      "California",
      "Delaware",
      "District of Columbia",
      "Idaho",
      "Indiana",
      "Maryland",
      "Massachusetts",
      "Minnesota",
      "Mississippi",
      "Montana",
      "Nebraska",
      "Nevada",
      "New Hampshire",
      "New Jersey",
      "New Mexico",
      "New York",
      "Oklahoma",
      "Pennsylvania",
      "Rhode Island",
      "Utah",
      "Vermont"
    ],
    "state_share_semantics": "For affected jurisdictions, the reported age-65-plus gross-cost total and share are lower bounds because one or more product-level age fields are suppressed."
  },
  "sources": {
    "cms_dataset_page": "https://data.cms.gov/provider-summary-by-type-of-service/medicare-part-d-prescribers/medicare-part-d-prescribers-by-geography-and-drug",
    "cms_2023_csv": "https://data.cms.gov/sites/default/files/2025-04/9fe6b8a6-0cb9-4b7c-9760-87800da010a8/MUP_DPR_RY25_P04_V10_DY23_Geo.csv",
    "cms_2024_csv": "https://data.cms.gov/sites/default/files/2026-05/3e80b44e-5a87-4414-959a-b6a7c8c18720/MUP_DPR_RY26_P04_V10_DY24_Geo.csv",
    "cms_methodology": "https://data.cms.gov/resources/medicare-part-d-prescribers-methodology",
    "cms_data_dictionary": "https://data.cms.gov/resources/medicare-part-d-prescribers-by-geography-and-drug-data-dictionary",
    "fda_glp1_product_list": "https://www.fda.gov/media/175358/download"
  },
  "source_sha256": {
    "MUP_DPR_RY25_P04_V10_DY23_Geo.csv": "876ff262c8a3eb0b8fca312f2004f14d42a8bfd01829e0695d64e34b5191f4f8",
    "MUP_DPR_RY26_P04_V10_DY24_Geo.csv": "c84a834ffb34fa1e46c6b8566d1e89d87f40390120393342e050f7203ef3ed68"
  }
}